Clinical Trial: Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Observational
Official Title: Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia
Brief Summary:
The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resistant hypertension. The primary endpoint is the change in mean blood pressure after 10 treatments .
In addition, data are collected on the immune system as well as for food and sleep quality.
Detailed Summary:
Sponsor: Herrmann Apparatebau GmbH
Current Primary Outcome: Change of blood pressure [ Time Frame: 3 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Change of pulse [ Time Frame: 3 months ]The Pulse will be measured at each follow-up. It will be measured 3 times at the dominate arm.
- Change of blood count, liver and nephrew values [ Time Frame: 3 months ]The change of blood counts, liver and nephrew values serves as a sign for change of immune activity in a patient. Furthermore potential negative effects will be reportet as an adverse event.
- Change of liver and nephrew values [ Time Frame: 3 months ]
- Change of life and Sleeping quality [ Time Frame: 3 months ]Change of life and sleeping quality will be measured in a 7 scale. This questionnaire is to fill in by the patient.
Original Secondary Outcome: Same as current
Information By: Herrmann Apparatebau GmbH
Dates:
Date Received: July 15, 2013
Date Started: August 2013
Date Completion: June 2014
Last Updated: August 12, 2013
Last Verified: August 2013